Log in to search using one of your social media accounts:

 

How to Do a Skin Cancer Body Check
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 16, 2017 Category: Cancer & Oncology Source Type: news

How to Do a Skin Cancer Body Check
WEDNESDAY, Nov. 15, 2017 -- Every year, about 5 million Americans are treated for skin cancer -- an abnormal growth of skin cells that most often develops on areas exposed to the sun. You can spot early signs by regularly checking your skin for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 15, 2017 Category: General Medicine Source Type: news

How to Do a Skin Cancer Body Check
Title: How to Do a Skin Cancer Body CheckCategory: Health NewsCreated: 11/15/2017 12:00:00 AMLast Editorial Review: 11/15/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 15, 2017 Category: Cancer & Oncology Source Type: news

Nigeria:Handheld Device Detects Cancer Via Skin
[Guardian] An affordable and effective device for detecting skin cancer has picked up an award of £30,000 ($40,000) from Britain's best-known inventor. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 14, 2017 Category: African Health Source Type: news

A Radioactive Cloud from Russia Swept Over Europe — and No One Knows Why
A mysterious radioactive cloud that swept through much of Europe this fall has officials baffled. The cloud was harmless and has dissipated, France’s Institute for Radiological Protection and Nuclear Safety wrote in a statement Thursday, but between Sept. 27 and Oct. 13, the radioactive nuclide Ruthenium 106 was detected in “the majority of European countries.” Experts aren’t totally sure where the substance came from, though testing suggests it was first released during the last week of September in Russia or Kazakhstan, likely somewhere between Russia’s Volga River and Ural Mountains. &ldquo...
Source: TIME.com: Top Science and Health Stories - November 10, 2017 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized europe France Nuclear onetime radiaoctive Science Source Type: news

Cameroon:When a Beauty Technique Is Cancerous!
[Cameroon Tribune] Some of the products used in bleaching the skin are said to be potential cause to skin cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 10, 2017 Category: African Health Source Type: news

Ludwig researchers uncover novel mechanism by which tumors evade cancer immunotherapies
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumors of the aggressive skin cancer melanoma can resist cancer immunotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news

Cancer immunotherapy uses melanin against melanoma
(North Carolina State University) Researchers have developed a melanin-enhanced cancer immunotherapy technique that can also serve as a vaccine, based on early experiments done in a mouse model. The technique is applied via a transdermal patch. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 10, 2017 Category: Biology Source Type: news

Advancing the treatment of melanoma
There is still a lot to learn about the genetic changes that occur as melanoma tumours form - and about the body's response to this illness. Greater understanding could help to predict how individual tumours are likely to respond to various combinations of therapies. An EU-funded network is training young researchers who are exploring this issue. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 10, 2017 Category: Research Source Type: news

OncoSec Medical names new CEO | Personnel Moves – Nov. 9, 2017
OncoSec Medical (NSDQ:ONCS)  announced earlier this week that the company’s co-founder, Punit Dhillon, would step down as CEO and continue to serve as president while Daniel O’Connor takes over the corner office. O’Connor joined OncoSec’s board of directors in September this year. “We are pleased to welcome Dan to OncoSec at this important time, and believe he is uniquely qualified to lead the company through the successful completion of its phase IIb registration directed trial, Pisces/Keynote-695 in patients with unresectable metastatic melanoma who have progressed or are progressi...
Source: Mass Device - November 9, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Wall Street Beat Aerie Pharmaceuticals Anika Therapeutics Inc. bostonbiomedical BrainStorm Cell Therapeutics Inc. DelMar Pharmaceuticals Express Scripts GlaxoSmithKline plc Onc Source Type: news

Skin cancer detecting device picks up £30,000 Dyson prize
A team of medical and bioengineering undergraduates from McCaster University in  Hamilton, Ontario, created the non-invasive test that can indicate cancerous skin tissue. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2017 Category: Consumer Health News Source Type: news

Low-cost device to diagnose skin cancer wins international Dyson award
Hand-held device dubbed sKan measures skin temperature to quickly and accurately identify melanoma, and could save lives around the worldA low-cost hand-held device which could help save lives across the world by diagnosingskin cancer early has won its inventors a prestigious international award and cash prize of £30,000.Four graduates ofMcMaster University in Canada have scooped theJames Dyson award for their invention, dubbed sKan: an easy-to-use gadget which measures skin temperature to quickly and accurately identify melanoma.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 9, 2017 Category: Science Authors: Rebecca Smithers Consumer affairs correspondent Tags: Science prizes Cancer research James Dyson Technology Skin cancer Health Medical research Society Source Type: news

UCLA helps many to live long and prosper
In Westwood, more than 100 faculty experts from 25 departments have embarked on anall-encompassing push to cut the health and economic impacts of depression in half by the year 2050. The mammoth undertaking will rely on platforms developed by the new Institute for Precision Health, which will harness the power of big data and genomics to move toward individually tailored treatments and health-promotion strategies.On the same 419 acres of land, researchers across the spectrum, from the laboratory bench to the patient bedside, are ushering in a potentially game-changing approach to turning the body ’s immune defenses a...
Source: UCLA Newsroom: Health Sciences - November 9, 2017 Category: Universities & Medical Training Source Type: news

Canadian skin cancer detector concept wins global design prize
Canadian students have won a global design prize by developing an early prototype of a cheap, handheld heat scanner that could one day help doctors diagnose skin cancer quickly and painlessly in their offices. (Source: CBC | Health)
Source: CBC | Health - November 8, 2017 Category: Consumer Health News Tags: News/Technology & Science Source Type: news

Waiting Even a Month to Remove Melanoma Can Be Deadly
Title: Waiting Even a Month to Remove Melanoma Can Be DeadlyCategory: Health NewsCreated: 11/7/2017 12:00:00 AMLast Editorial Review: 11/8/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 8, 2017 Category: Cancer & Oncology Source Type: news

Bringing natural killer cells to the tumor battlefield
(Luxembourg Institute of Health) By studying melanoma, a highly malignant form of skin cancer, Dr Bassam Janji's research team at the Luxembourg Institute of Health (LIH) has revealed a mechanism by which the immunosuppressive environment can be switched to an immunosupportive one. They found that if autophagy -- the intracellular recycling process -- is blocked in tumor cells, they produce cytokines that attract NK cells. The massive recruitment of NK cells allows killing cancer cells and lets the tumors shrink. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Advancing women's health through scientific mobility
A Marie Skłodowska-Curie fellowship grant has enabled an ambitious young French researcher to make important advances in identifying a possible genetic association between endometriosis (when tissue that normally grows inside the uterus grows outside) and a higher risk of developing melanoma, a skin cancer. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - November 8, 2017 Category: Research Source Type: news

Waiting Even a Day to Remove Melanoma Can Be Deadly
No matter what stage their cancer was, those who waited more than 90 days for surgical treatment were more likely to die. (Source: WebMD Health)
Source: WebMD Health - November 7, 2017 Category: Consumer Health News Source Type: news

Waiting Even a Month to Remove Melanoma Can Be Deadly
Source: HealthDay Related MedlinePlus Pages: Melanoma (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 7, 2017 Category: Consumer Health News Source Type: news

Waiting Even a Month to Remove Melanoma Can Be Deadly
TUESDAY, Nov. 7, 2017 -- The sooner the deadly skin cancer melanoma is treated, the more likely a patient is to survive. Researchers analyzed data from more than 153,000 American adults diagnosed with stage 1 to 3 melanoma between 2004 and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 7, 2017 Category: General Medicine Source Type: news

Circulating tumor cells associated with relapse in late-stage melanoma patients
(University of Texas M. D. Anderson Cancer Center) A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as a potential predictor of patients at high risk for disease progression. CTCs, tumor cells shed into the bloodstream or lymphatic system, can lead to additional tumor growth and/or metastasis to distant sites. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news

Waiting Even a Month to Remove Melanoma Can Be Deadly
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news

FDA approves Roche drugs for rare types of blood, lung cancers
(Reuters) - Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood cancer, and to market its drug Alecensa as a first choice of treatment for a subset of patients with non-small cell lung cancer. (Source: Reuters: Health)
Source: Reuters: Health - November 6, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Should Some Oropharyngeal Cancer Patients Skip Adjuvant Chemo, Radiation With TORS? Should Some Oropharyngeal Cancer Patients Skip Adjuvant Chemo, Radiation With TORS?
For patients with oropharyngeal squamous cell carcinoma (OPSCC) receiving transoral robotic surgery (TORS), adjuvant radiotherapy or chemoradiotherapy (CRT) should be avoided if possible, according to a long-term functional and quality-of-life (QOL) outcomes study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 6, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

First Tx for Erdheim-Chester Disease, a Rare Blood Cancer First Tx for Erdheim-Chester Disease, a Rare Blood Cancer
The first FDA-approved treatment for Erdheim-Chester dDisease (ECD), a rare blood cancer, is vemurafenib, a targeted therapy already used in melanoma with BRAF V600E mutations.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA approves Roche drug for rare type of blood cancer
(Reuters) - Roche Holding AG won U.S. approval to market its skin cancer drug Zelboraf for certain patients with Erdheim-Chester Disease, a rare type of blood cancer. (Source: Reuters: Health)
Source: Reuters: Health - November 6, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Kent sunbed addict left with hole in face from skin cancer
Elaine Sheaf, 62, from Rochester, Kent, needed 15 gruelling procedures to cut away her facial tumours. She believes the cancer was caused by her use of tanning beds 4 decades ago. (Source: the Mail online | Health)
Source: the Mail online | Health - November 6, 2017 Category: Consumer Health News Source Type: news

What Causes White Nails?
Discussion The nail matrix covers the area of the nail plate, and extends proximally in a crescent moon shape with the edges of the crescent extending proximally and inferiorly toward the underlying bone. The nail matrix is a multilayered epithelium that physiologically produces keratinization and gives rise to the nail plate. The distal matrix forms the lower 2/3s of the nail plate and the proximal matrix forms the upper 1/3 of the nail plate. the thickness of the nail plate is proportion to the matrix’s thickness. The nail plate’s free edge contour follows the shape of the nail’s lunula. Melanocytes occ...
Source: PediatricEducation.org - November 6, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

7 medtech stories we missed this week: Nov. 3, 2017
[Image from unsplash.com]From Hologic’s new product launch to CapsoVision gettting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Hologic launches new MyoSure device Hologic announced in a Nov. 1 press release that it has launched its MyoSure Manual Device in the U.S. The device is designed to help doctors resect and remove intrauterine tissue easily in an office setting if used with the MyoSure hysteroscope. 2. IntraFuse wins FDA clearance for FlexThread fibula pin IntraFuse has received FDA 510(k) clearance for its FlexThread Fibula Pin System, ...
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Endoscopic / Arthroscopic Oncology Orthopedics Pain Management Regulatory/Compliance Surgical Ultrasound Women's Health brhmedical CapsoVision Helomics Hologic Inc. IntraFuse MedTech Sensus Healthcare LLC Skyline Med Source Type: news

Cancer treatment response may be affected by gut bacteria
Conclusion This early-stage study gives us some insights into factors that might influence people's responses to a specific type of cancer treatment (immunotherapy with monoclonal antibodies). The findings are of interest, but don't have any immediate implications for cancer treatment. We don't know what the conditions that required antibiotic treatment were and whether these could have affected the response to immunotherapy. We don't know whether the antibiotics themselves influenced how well the immunotherapy worked, or whether it was their effect on gut bacteria. We also don't know whether having high levels of part...
Source: NHS News Feed - November 3, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Scheme published to fast-track access to crucial medicines
Big Pharma boss appointed to lead the new pathway Related items fromOnMedica Pharmaceutical industry regulation undermines NICE drugs appraisal work NICE fast-tracks approval of new skin cancer treatment UK spends 20% less on cancer treatment than rest of EU Pharma trade body rejects appeal for judicial review after High Court ruling The medicine price debate (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 3, 2017 Category: UK Health Source Type: news

Mom's Skin Cancer Pic Shoots Around the Web
California mom Kari Cummins didn't think much of it when she first shared pictures of her skin cancer on social media. But one image in particular -- of a large hole in the lower part of her face -- shot around the internet. (Source: WebMD Health)
Source: WebMD Health - November 2, 2017 Category: Consumer Health News Source Type: news

Having a curved penis brings a higher risk of cancer
A study of 1.5million men by Baylor College in Houston, Texas, found that a curved penis causes a higher risk of testicular cancer by 40%, melanoma by 29% and stomach cancer by 40%. (Source: the Mail online | Health)
Source: the Mail online | Health - November 2, 2017 Category: Consumer Health News Source Type: news

Bacteria in the gut modulates response to immunotherapy in melanoma
(University of Texas M. D. Anderson Cancer Center) Bacteria that live in the human digestive tract can influence how cancer responds to immunotherapy, opening a new avenue for research to improve treatment, a team led by researchers at The University of Texas MD Anderson Cancer Center reports in the journal Science. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2017 Category: Cancer & Oncology Source Type: news

A squamous cell carcinoma that disproportionately affects men
Factors that drive lip squamous cell carcinomas in men. (Source: Dermatology Times)
Source: Dermatology Times - November 1, 2017 Category: Dermatology Source Type: news

Health Tip: Avoid UV Radiation
Too much could lead to skin cancer (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 1, 2017 Category: Cancer & Oncology Source Type: news

Adjuvant BRAF and MEK Inhibition for Melanoma:'Impressive'Adjuvant BRAF and MEK Inhibition for Melanoma:'Impressive '
New at ESMO 2017, adjuvant dabrafenib/trametinib in stage III melanoma shows'impressive'results in relapse-free survival.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Health Tip: Avoid UV Radiation
Too much could lead to skin cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 31, 2017 Category: Cancer & Oncology Tags: Dermatology, Oncology, FYI, Source Type: news

Health Tip: Avoid UV Radiation
-- Ultraviolet (UV) radiation coming from the sun is a major cause of skin cancer. The American Cancer Society suggests how to minimize the effects of UV rays: UV rays are strongest between the hours of 10 am and 4 pm. If you must be outside during... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 31, 2017 Category: General Medicine Source Type: news

Merkel Cell Carcinoma: Not Just Another Skin Cancer Merkel Cell Carcinoma: Not Just Another Skin Cancer
Merkel cell expert Paul Nghiem, MD, PhD, explains how this rare but deadly condition differs from other forms of skin cancer.Medscape Dermatology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 27, 2017 Category: Pathology Tags: Dermatology Expert Interview Source Type: news

Almost 4 in 10 Tanning Salons Flout State Laws
Survey finds many salons willing to offer tanning to teens, despite legal bans Source: HealthDay Related MedlinePlus Pages: Skin Cancer, Tanning (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 25, 2017 Category: Consumer Health News Source Type: news

Cannock mother diagnosed with skin cancer thanks to app
Natalie Killian, 39, from Cannock, West Midlands, became worried about her risk of skin cancer because of her previous tanning habits, which would see her go for a sunbed five times a week. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2017 Category: Consumer Health News Source Type: news

Mother, 39, diagnosed with skin cancer thanks to phone app
Natalie Killian, 39, from Cannock, West Midlands, became worried about her risk of skin cancer because of her previous tanning habits, which would see her go for a sunbed five times a week. (Source: the Mail online | Health)
Source: the Mail online | Health - October 25, 2017 Category: Consumer Health News Source Type: news

BIOCAD enters the European market
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there are seven molecules in the European portfolio of BIOCAD. This are innovative and biosimilar products, which could be used in treatment of melanoma, breast, stomach, kidney and lung cancer, rheumatoid arthritis, psoriasis and multiple sclerosis. (Source: World Pharma News)
Source: World Pharma News - October 25, 2017 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news

No Efficacy Hit from Stopping Immunotherapy for AEs (CME/CE)
(MedPage Today) -- Response and median survival don't seem to suffer in advanced melanoma (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - October 24, 2017 Category: Consumer Health News Source Type: news

Mary Seacole Awards for gang mental health and skin cancer
The winners of this year ’s Mary Seacole Leadership and Development Awards, which fund projects to improve the health of people from black and minority ethnic communities, have been revealed. (Source: Nursing Times)
Source: Nursing Times - October 24, 2017 Category: Nursing Source Type: news

Skin Cancer Melanoma Squamous Cell Basal Cell
Skin Cancer (Melanoma, Squamous Cell, Basal Cell Cancer) in Children (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 24, 2017 Category: General Medicine Source Type: news

Researchers find lung cancer driver in non-sun melanoma
Researchers know all melanomas are not alike but a new study has revealed how much different non-sun-related melanomas are from sun-related melanomas. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 23, 2017 Category: Consumer Health News Source Type: news

Novartis gets FDA breakthrough status for Tafinlar, Mekinist combination
ZURICH (Reuters) - Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and Mekinist to treat patients with BRAF V600-positive stage III melanoma following surgery. (Source: Reuters: Health)
Source: Reuters: Health - October 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Lung cancer driver ALK-fusion found in melanoma
(University of Colorado Anschutz Medical Campus) A University of Colorado Cancer Center study published today in the journal Molecular Cancer Therapeutics finds a genetic change called ALK-fusion in a patient sample of a melanoma subtype called mucosal melanoma. When researchers treated a tumor grown from this sample with the drugs crizotinib and ceritinib -- both FDA approved to treat ALK-positive lung cancer -- the tumor responded dramatically. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2017 Category: Cancer & Oncology Source Type: news